Growth Metrics

Merck (MRK) Assets Average (2016 - 2025)

Merck (MRK) has disclosed Assets Average for 15 consecutive years, with $106.7 billion as the latest value for Q4 2023.

  • On a quarterly basis, Assets Average fell 1.31% to $106.7 billion in Q4 2023 year-over-year; TTM through Dec 2023 was $106.7 billion, a 1.31% decrease, with the full-year FY2025 number at $127.0 billion, up 13.49% from a year prior.
  • Assets Average was $106.7 billion for Q4 2023 at Merck, up from $105.6 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $108.5 billion in Q1 2023 to a low of $82.5 billion in Q1 2019.
  • A 5-year average of $99.6 billion and a median of $106.1 billion in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: dropped 5.13% in 2019, then grew 17.75% in 2022.
  • Merck's Assets Average stood at $83.9 billion in 2019, then rose by 8.14% to $90.7 billion in 2020, then grew by 0.08% to $90.8 billion in 2021, then rose by 19.12% to $108.1 billion in 2022, then dropped by 1.31% to $106.7 billion in 2023.
  • Per Business Quant, the three most recent readings for MRK's Assets Average are $106.7 billion (Q4 2023), $105.6 billion (Q3 2023), and $106.1 billion (Q2 2023).